Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,752.82
1,424.75
1,847.68
3,065.48
3,730.70
4,459.82
3,869.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,752.82
1,424.75
1,847.68
3,065.48
3,730.70
4,459.82
3,869.72
Raw Material Cost
362.26
309.05
290.81
343.37
368.32
387.33
333.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
160.58
198.00
246.42
245.68
238.24
248.77
203.53
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.97
3.08
3.46
4.28
3.23
0.36
0.78
Selling and Distribution Expenses
1,136.65
957.76
1,310.44
2,129.94
2,410.17
2,956.20
2,556.72
Other Expenses
-0.16
25.28
30.88
3.23
-2.03
2.73
6.05
Total Expenditure (Excl Depreciation)
1,660.85
1,720.72
2,159.98
2,755.55
2,999.64
3,619.95
3,154.69
Operating Profit (PBDIT) excl Other Income
92
-296
-312.3
309.9
731.1
839.9
715
Other Income
46.48
81.05
70.58
87.69
86.99
48.22
40.68
Operating Profit (PBDIT)
231.50
-125.24
-165.25
496.87
913.91
978.32
838.87
Interest
2.97
3.08
3.46
4.28
3.23
0.36
0.78
Exceptional Items
12.73
12.50
1.68
1.54
-0.26
-1.23
0.00
Gross Profit (PBDT)
1,390.57
1,115.70
1,556.87
2,722.11
3,362.38
4,072.49
3,536.61
Depreciation
92.18
87.42
97.86
98.55
94.57
88.80
83.15
Profit Before Tax
149.08
-203.25
-264.88
395.58
815.85
887.93
754.93
Tax
22.98
6.55
3.70
25.51
95.83
108.03
86.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
160.29
-148.53
-225.83
379.91
721.63
780.96
670.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
160.29
-148.53
-225.83
379.91
721.63
780.96
670.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-31.82
-58.95
-40.38
0.66
3.74
-1.06
-1.17
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
128.47
-207.48
-266.21
380.56
725.37
779.90
668.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,062.65
2,899.99
2,962.97
3,218.68
3,027.15
2,513.55
1,844.87
Earnings per share (EPS)
0.17
-0.16
-0.24
0.41
0.78
0.84
3.89
Diluted Earnings per share
0.17
-0.16
-0.24
0.41
0.78
0.84
3.89
Operating Profit Margin (Excl OI)
5.3%
-20.61%
-18.06%
10.13%
19.63%
18.86%
18.48%
Gross Profit Margin
13.76%
-8.13%
-9.04%
16.12%
24.4%
21.9%
21.66%
PAT Margin
9.14%
-10.42%
-12.22%
12.39%
19.34%
17.51%
17.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 23.03% vs -22.89% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 161.93% vs 22.05% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 189.68% vs 12.51% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -3.23% vs -11.43% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Beijing Aosaikang Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,752.82
0
1,752.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,752.82
0
1,752.82
Raw Material Cost
362.26
0
362.26
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
160.58
0
160.58
Power Cost
0
0
0.00
Manufacturing Expenses
2.97
0
2.97
Selling and Distribution Expenses
1,136.65
0
1,136.65
Other Expenses
-0.16
0.00
-0.16
Total Expenditure (Excl Depreciation)
1,660.85
0
1,660.85
Operating Profit (PBDIT) excl Other Income
91.97
0.00
91.97
Other Income
46.48
0
46.48
Operating Profit (PBDIT)
231.50
0
231.50
Interest
2.97
0
2.97
Exceptional Items
12.73
0
12.73
Gross Profit (PBDT)
1,390.57
0
1,390.57
Depreciation
92.18
0
92.18
Profit Before Tax
149.08
0
149.08
Tax
22.98
0
22.98
Provisions and contingencies
0
0
0.00
Profit After Tax
160.29
0
160.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
160.29
0
160.29
Share in Profit of Associates
0
0
0.00
Minority Interest
-31.82
0
-31.82
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.47
0
128.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,062.65
0
3,062.65
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
5.30%
0%
0.00
5.30%
Gross Profit Margin
13.76%
0%
0.00
13.76%
PAT Margin
9.14%
0%
0.00
9.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 175.28 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 23.03% vs -22.89% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 12.85 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 161.93% vs 22.05% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.50 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 189.68% vs 12.51% in Dec 2023
Annual - Interest
Interest 0.30 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -3.23% vs -11.43% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.30%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






